Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
COVID-19 Therapeutics
Sort By
Newest First
Sign in
1 / 1
1 / 1
COVID-19 Prevention
AstraZeneca to Supply Canada with 100,000 Doses of Evusheld, a Long-Acting Antibody Combination for the Prevention of COVID-19
AstraZeneca Canada
PR-M02-22-21
Feb 23, 2022
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05
Feb 08, 2022
Cleanrooms
Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned
Grant Merrill; Jose Jimenez
AES Clean Technology Inc.
PAO-06-21-CL-06
Jun 18, 2021
COVID-19 Therapeutics
Tevogen Bio Announces Partnership With BioCentriq to Enhance Tevogen’s Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19
Tevogen Bio
PR-M03-21-002
Mar 15, 2021
COVID-19 Therapeutics
How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic
Jonathan C. Javitt, M.D., M.P.H.
NeuroRx
PAP-Q4-20-CL-017
Dec 09, 2020
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
Theresa Deisher, Ph.D.
AVM Biotechnology
PAP-Q4-20-CL-005
Dec 09, 2020
